Sarcolipin (SLN) and phospholamban (PLN) are two small proteins that regulate the sarco (endo)plasmic reticulum Ca 2+ -ATPase pumps. In a recent study, we discovered that Pln overexpression (Pln OE ) in slow-twitch type I skeletal muscle fibers drastically impaired SERCA function and caused a centronuclear myopathy-like phenotype, severe muscle atrophy and weakness, and an 8 to 9-fold upregulation of SLN protein in the soleus muscles. Here, we sought to determine the physiological role of SLN upregulation, and based on its role as a SERCA inhibitor, we hypothesized that it would represent a maladaptive response that contributes to the SERCA dysfunction and the overall myopathy observed in the Pln 
Introduction
The muscle proteins, sarcolipin (SLN) and phospholamban (PLN), are two well-known regulators of sarco(endo)plasmic reticulum Ca 2+ -ATPase (SERCA) pumps [1, 2] . We have recently discovered that type I fiber specific PLN overexpression in mice (Pln OE ) causes severe impairments in SERCA function and a centronuclear myopathy (CNM)-like phenotype in the soleus and gluteus minimus muscles [3] . Along with severe muscle atrophy and weakness, these a1111111111 a1111111111 a1111111111 a1111111111 a1111111111 muscles displayed the three main histological features associated with CNM: 1) increased central nuclei, 2) central aggregation of oxidative activity, and 3) type I fiber predominance and hypotrophy [4] . SLN protein was upregulated 7-9 fold in the soleus and gluteus minimus muscles from Pln OE mice compared with wild-type (WT) [3] , a feature that is common among other mouse models of muscle disease where SLN is often upregulated [5] [6] [7] [8] [9] [10] [11] [12] . However, the physiological role of SLN upregulation in Pln OE mice remains unknown.
Co-expression of SLN and PLN at supraphysiological levels in HEK-293 cells results in superinhibition of calcium uptake [13] . Although the exact mechanisms leading to CNM is unclear, aberrant calcium handling [14, 15] has been suggested to have a pathological role. SERCA inhibition and the concomitant rise in [Ca 2+ ] i could lead to the generation of reactive oxygen species [16] and activation of the Ca 2+ -dependent calpain proteases [17, 18] ultimately leading to muscle wasting. Since forced over-expression of SLN in skeletal muscle represses SR Ca 2+ uptake and impairs contractile function [19] and SLN ablation enhances Ca 2+ transport and muscle relaxation [20] , we hypothesized that preventing the upregulation of SLN protein in Pln OE mice may mitigate CNM pathology and combat the muscle atrophy and weakness that occurs. To test this hypothesis, we crossed Sln-null (Sln KO ) mice [21] with heterozygous Pln OE mice [3] and examined the effect on SERCA function, CNM pathology, soleus muscle mass, and contractile function.
Methods

Mice
The Pln OE and Sln KO mice have been described previously [3, 21] . To direct type I fiber specific
Pln overexpression, the Pln transgene was attached to the β-myosin heavy chain (MHC) promoter [22] , which directs high levels of type I skeletal-muscle specific transgene expression [23] [24] [25] . FVB/N Pln OE mice were resuscitated from cryopreserved embryos by the mmRRC (000067-MU) to generate a breeding colony with WT FVB/N mice in our facility. Since the Sln KO mice were generated onto a C57BL/6J background [21] , we backcrossed heterozygous male FVB/N Pln OE animals with either C57BL/6J Sln KO (Sigma C7522) using a spectrophotometric plate reader assay as previously described [26] . Maximal SERCA activity was taken from the raw data and SERCA activity-pCa curves were generated with GraphPad Prism TM (CA, USA) by non-linear regression curve fitting using an equation for a general cooperative model for substrate activation. Ca 2+ uptake was measured at a free [Ca 2+ ] of 1500 nM in soleus homogenates in the presence of precipitating anion, oxalate, using the fluorescent dye Indo-1 and a spectrofluorometer equipped with dual-emission monochromators [27] . . Muscles were situated between two platinum electrodes and force was electrically evoked and assessed across a range of stimulation frequencies from 1 to 100 Hz using a biphasic stimulator (Model 710B, Aurora Scientific, Inc., ON, Canada). Data were analyzed using Dynamic Muscle Control Data Acquisition software (Aurora Scientific). Specifically, peak isometric force amplitude (mN) and the maximal rates of force development (+dF/dt) and relaxation (−dF/dt) were determined during a twitch and across the range of stimulation frequencies. Peak isometric force was then normalized to muscle weight (mN/g).
In vitro muscle contractility
Antibodies
Primary antibodies against PLN (2D12), phosphorylated-NFATc1 (PA5-38301), total NFATc1 (MA3-024), SERCA2a (MA3-919), ryanodine receptor 1 (RyR, MA3-925), dihydropyridine receptor α1 subunit (DHPR, MA3-920), and calsequesterin I and II (CSQ, MA3-913) were obtained from Pierce Antibodies. The primary antibody directed against SLN was generated by Lampire Biological Laboratories (PA, USA) [28] . LC3B (2775) and p62 (GP62-C) antibodies were obtained from Cell Signaling Technology (MA, USA) and Progen Biotechnik (Heidelberg, Germany), respectively. The primary antibody against actin (A2066) and stabilin-2 (orb158499) were obtained from Sigma Aldrich (MO, USA), and Biorbyt (CA, USA), respectively. SERCA1a antibody (A52) was a kind gift from Dr. David MacLennan (University of Toronto) [29] . and RYR; and ECL Western Blot Substrate (BioVision, MA, USA) for total NFAT, SERCA1a, SERCA2a, CSQ, DHPR, LC3 and p62. Quantification of optical densities was performed using GeneTools (Syngene, MD, USA) and values were normalized to the densitometric sum of all bands visualized through ponceau staining or actin. For RyR, DHPR, and CSQ analyses, the same PVDF membrane was used and cut into their corresponding strips (RyR > 250 kDa; DHPR 100-250 kDa; and CSQ < 100 kDa).
Electron microscopy
To examine the triad structures in the soleus muscles of WT, Pln 
Proteolytic enzyme activity assays
Caspase-3 and cathepsin-B/L activity were determined in soleus muscle homogenates using the substrates Ac-DEVD-AMC (Alexis Biochemicals) and z-FR-AFC (Enzo Life Sciences, NY, USA), respectively, whereas calpain and 20S proteasome activity were determined using Suc-LLVY-AMC (Enzo-Life Sciences) [3] . These fluorogenic substrates are weakly fluorescent but yield highly fluorescent products following proteolytic cleavage by their respective proteases. Fluorescence was measured using a SPECTRAmax Gemini XS microplate spectrofluorometer (Molecular Devices, Sunnyvale, CA) with excitation and emission wavelengths of 360 nm and 440 nm (caspase-3), 380 nm and 460 nm (calpain and 20S proteasome), or 400 nm and 505 nm (cathepsin), respectively. To distinguish between calpain and 20S proteasome activity, the specific inhibitors Z-Leu-Leu-CHO (calpain; Enzo-Life Sciences) and epoxomicin (20S proteasome; Cayman Chemical, MI, USA) were incubated and the difference in fluorescence from homogenates incubated with and without the respective inhibitors was measured. All proteolytic activities were normalized to total protein content and expressed as fluorescence intensity in arbitrary units per mg of protein.
Daily activity and food intake measurements
Daily food consumption (g/day) and cage activity were measured using a comprehensive laboratory animal monitoring system (CLAMS; Oxymax series; Columbus Instruments, Columbus, OH, USA) as previously described [31] . This system is equipped with a feed scale for monitoring mass of food consumed, as well as X-and Z-axes infrared photocell detectors that allow for monitoring ambulatory activity (when 2 adjacent x-axis beams were broken in succession) and total cage activity. Mice were placed in the CLAMS for a 3-day period for 3 separate trials and had free access to food and water.
Statistics
All values are presented as means ± standard error (SEM 
Results
Effect of Sln ablation on SERCA function
Similar to the FVB/N line [3] we observed an 8-fold upregulation of SLN protein in the Pln OE soleus, and we confirmed the lack of SLN protein after genetic deletion of Sln (Fig 1A) .
Removal of Sln did not alter the level of monomeric or pentameric PLN overexpression ( Fig   Fig 1. Sln deletion (Fig 2A) . Assessment of the other major Ca 2+ regulatory proteins including SERCA1a, SERCA2a, DHPR, RyR, and CSQ did not reveal any significant differences (Fig 2B-2F) . (Fig 3A-3F) . Consistent with other models of CNM and biopsies from CNM patients [32] [33] [34] [35] , TEM analyses revealed triad abnormalities with swollen sarcoplasmic reticulum membranes in both the Pln OE and Pln OE /Sln KO soleus muscles (Fig 3G) . In addition to this and in agreement with our initial characterization of the Pln OE mice [3] , endomysial fibrosis and core-like lesions were evident in the Pln OE and Pln OE / Sln KO soleus (Fig 3H-3J) . Collectively, these data suggest that Sln deletion had very little effect on the overall CNM phenotype that occurs with PLN overexpression. The Effects of Sln deletion in Pln
Effect of Sln deletion on muscle size and contractile function
The absence of SLN exacerbated the soleus muscle atrophy seen with PLN overexpression [3, 22] (Fig 3F and refer- ence [3] ), and the type IIX fibers showed a similar pattern ( Fig 3F) ; however the one-way ANOVA did not indicate statistical significance (p = 0.11). There was also a significant reduction in total fiber count in the Pln OE /Sln KO soleus muscles compared with both Pln OE and WT mice (Fig 4B) . Soleus muscles from Pln OE /Sln KO mice displayed significant reductions in mass-specific force from 50-100Hz stimulation compared with WT ( Fig 4C) . In contrast, the Pln OE soleus muscles were only significantly weaker than WT at 100 Hz (Fig 4C) . . Importantly, body weight, daily food intake, and daily activity were not different between groups (Table 1) , and therefore cannot explain the worsened soleus muscle atrophy and weakness.
Fiber type distribution
In response to Pln overexpression in the slow-twitch type I fibers, the type II fibers decrease in proportion while the type I fibers increase [3, 22] . A similar result was observed in this study with significant reductions in both type IIA and type IIX fiber percentages in Pln OE mice compared with WT ( Fig 3E) . In contrast, the type IIA fiber distribution in the Pln OE /Sln KO was not different from WT (Fig 3E) suggestive of a delayed fast-to-slow fiber type shift.
NFATc1 phosphorylation and stabilin-2 expression as markers of calcineurin signaling
To explain the lack of type II fiber hypertrophy and the delay in the fast-to-slow fiber type shift in the absence of Sln, we focused on calcineurin, the Ca 2+ -calmodulin dependent serine/threonine phosphatase known to regulate these cellular adaptations [36] [37] [38] and, perhaps more importantly, shown to be responsive to SLN [39] . When examining the phosphorylation status of nuclear factor of activated T-cells cytoplasmic 1 (NFATc1) as a marker of calcineurin signaling, compared with WT we found that NFATc1 phosphorylation relative to total NFATc1 was significantly lower in Pln OE but not Pln OE /Sln KO soleus (Fig 5A) . Calcineurin-mediated activation of NFATc1 increases the expression of stabilin-2; a phosphatidylserine receptor required for myoblast fusion [40] . Corresponding well with the significant dephosphorylation of NFATc1 only in the Pln OE mice, we found a significant elevation in stabilin-2 expression only in Pln OE soleus compared with WT ( Fig 5B) . Stabilin-2 expression was also higher in the Pln 
Assessment of the major proteolytic pathways and autophagy
Next, we tested whether elevated proteolytic activities could also contribute to the exacerbated soleus muscle atrophy seen in the Pln OE /Sln KO mice. Consistent with our previous study [3] , calpain, caspase-3, 20S proteasome and cathepsin activities were all significantly elevated in the Pln OE soleus compared with WT; however, none of these were augmented further in the Pln OE /Sln KO soleus (Fig 6A-6D) . In fact, only the 20S proteasome was significantly elevated in the Pln OE /Sln KO soleus compared with WT. Moreover, a trending reduction in p62 content (p = 0.10) and a significant increase in the LC3-II/I ratio in the Pln OE soleus, combined with consumption, ambulation, and total activity). Ambulatory activity counts were when the mouse crossed 2 adjacent x-axis infrared beams in succession. One-way ANOVA revealed no significant effect of genotype for body weight (p = 0.37), food intake (p = 0.48), total activity (p = 0.12), or dual beam activity (p = 0.17).
doi:10.1371/journal.pone.0173708.t001
The Effects of Sln deletion in Pln OE mice the elevated cathepsin activity, indicate greater autophagic signaling compared with WT ( Fig  6E and 6F) 
Discussion
In this study, we examined the physiological role of SLN upregulation in the Pln OE mouse model of CNM by generating the Pln OE /Sln KO mouse line. We hypothesized that SLN ablation would alleviate the CNM pathology, muscle atrophy, and weakness in this model through improvements in SERCA function. However, in contrast to our hypotheses, we did not observe any improvements in SERCA function or CNM phenotype in the Pln OE /Sln KO soleus, and found that Sln deletion actually exacerbated the soleus muscle atrophy and weakness by preventing the compensatory type II fiber hypertrophy and reducing the total myofiber count. In addition, rates of force development were slower in the Pln OE /Sln KO soleus compared with those from Pln OE mice, which could be due to excitation-contraction (E-C) coupling impairments related to triad structural defects. In a previous study with Sln overexpressing mice, SLN was shown to stimulate calcineurin [39] , a Ca 2+ -dependent phosphatase that is implicated in muscle growth [36, 38, 41] and promotion of the slow-oxidative phenotype [36, [41] [42] [43] [44] [45] . Pharmacological inhibition of calcineurin prevents myofiber hypertrophy and the fast-to-slow fiber type transition in plantaris muscles that have been mechanically overloaded after synergist ablation of the soleus and gastrocnemius [36, 41, 46] . We propose that the Pln OE soleus represents a model of intramuscular overload, whereby the type I fiber hypotrophy results in overload of the type II fibers within the soleus causing them to hypertrophy and transition towards the slow oxidative phenotype [3] . However, in the absence of SLN upregulation, the fast-to-slow fiber type shift and type II fiber hypertrophy are attenuated in the Pln OE mice.
A failure to dephosphorylate NFAT and increase expression of stabilin-2 are indicative of impaired calcineurin signaling in the Pln OE /Sln KO mice. It is well accepted that calcineurin activation is important for controlling muscle fibre type in adaptive muscle remodeling so lowered calcineurin activation can at least partly explain the blunted fast-to-slow fiber type shift in The Effects of Sln deletion in Pln [47, 48] , and genetically modified mice, characterized with either calcineurin inhibition or over-activation, display no effects on myofiber size or muscle mass [45, [49] [50] [51] . Nonetheless, calcineurin's role in myoblast fusion is well established [52] [53] [54] and recent evidence has shown that calcineurin activation, specifically through NFATc1, increases the expression of a phosphatidylserine receptor, stabilin-2, and that without stabilin-2, myoblast fusion, myofiber size, and muscle mass are severely reduced [40] . According to the myonuclear domain theory, an increase in the relative amount of nuclei per fibre, via enhanced myoblast fusion to pre-existing myofibers, will increase myofiber size and overall muscle mass [54, 55] . Collectively, our results suggest that the blunted calcineurin signalling in the Pln OE /Sln KO mice reduces stabilin-2 expression and likely impairs myoblast fusion, thereby contributing to the reductions in soleus size, type II fiber CSA, and force generation. Impairments in stabilin-2 and myoblast fusion could also contribute to the reduction in total fiber count we observed in the Pln OE /Sln KO mice, possibly via impaired muscle regeneration. While calcineurin's role in muscle regeneration has been well established [56] [57] [58] , it is important to note that CNMs, including the Pln OE mouse, generally do not display signs of extensive muscle regeneration [3, 59] . Alternatively, although excessive autophagy could be detrimental and may lead to muscle atrophy [60] , impaired autophagy also results in extensive myofiber degeneration [61] . Therefore, the impaired activation of autophagic signaling in the Pln OE /Sln KO soleus could also contribute to the reductions in total fiber count. Collectively, these results indicate that failure to promote both calcineurin and autophagic signaling in the Pln OE /Sln KO soleus, unlike the Pln OE soleus, likely contribute to the hypoplasia and the exacerbated muscle atrophy and weakness in this model. Upregulated SLN is a hallmark of several muscle diseases [5] [6] [7] [8] [9] [10] [11] [12] but it's unknown whether that response is adaptive or pathogenic. This is the first study to examine the role of SLN upregulation in any form of muscle myopathy and our results indicate that SLN upregulation is an adaptive response that may be required for optimal activation of calcineurin to combat the muscle atrophy and weakness that occurs in the Pln OE soleus. In the dystrophic mdx mouse model, the affected skeletal muscles show large upregulation of SLN [7] , and given the data presented here, this increase in SLN could potentially aid in activating calcineurin and autophagic signaling, both of which have been shown to be promising therapeutic strategies [57, [62] [63] [64] [65] [66] . In addition, corticosteroid [63] and high-fat feeding [67] can ameliorate dystrophic pathology in mdx mice, and both treatments lead to an increase in SLN expression [9, 31, 68] . Future studies aimed at examining the role of SLN across these different myopathies could further reveal the importance of SLN in overall muscle health. Our work also sheds light on the differences between PLN and SLN function in skeletal muscle. Our findings showing that PLN overexpression causes myopathy and muscle atrophy whereas SLN upregulation counters it, adds to the notion that PLN and SLN may not be functionally redundant [69] . Indeed, unlike the muscle weakness observed in Pln OE mice [3, 22] , Sln OE mice present with enhanced contractility [70] . It also appears that PLN is different from SLN in its ability to regulate calcineurin signaling since PLN overexpression alone without SLN upregulation resulted in greatly reduced calcineurin signaling. Given that both PLN and SLN are capable of inhibiting SERCA [13, 71, 72] , it is surprising that only SLN seems to be a significant regulator of calcineurin. Similarly, it appears that SLN but not PLN is capable of altering autophagy in skeletal muscle since PLN overexpression alone without SLN upregulation did not increase autophagic signaling. We speculate that SLN's influence on energy expenditure [73] may have a role in activating autophagy, whereas PLN may not have the same influence on ATP consumption in muscle [74] , but this needs to be explored further. In summary, we have found that SLN is upregulated in the soleus muscles from PLN overexpressing mice to combat muscle atrophy and weakness by promoting the compensatory type II fiber hypertrophy and maintaining total myofiber number through calcineurin activation and autophagic signaling. We did not find any alterations in the CNM phenotype in the Pln OE /Sln KO soleus, which suggests that SLN likely has no contribution to CNM pathology.
Increased SLN expression is a hallmark of muscle disease, which may represent an adaptive response that is necessary for muscle growth and remodeling and future studies should determine whether SLN provides a novel therapeutic target for other neuromuscular disorders.
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